Hamid Mostafavi Abdolmaleky | Neuroscience | Best Researcher Award

Best Researcher Award

Hamid Mostafavi Abdolmaleky
Affiliation BIDMC, Harvard Medical School
Country United States
Scopus ID 8744606800
Documents 71
Citations 4,072
h-index 29
Subject Area Neuroscience
Event Global Academic Awards
ORCID 0000-0002-8872-5174

Hamid Mostafavi Abdolmaleky

BIDMC, Harvard Medical School

The Best Researcher Award recognition profile highlights the scholarly achievements and scientific contributions of Hamid Mostafavi Abdolmaleky, a researcher affiliated with BIDMC and Harvard Medical School. His academic work has contributed to the advancement of neuroscience research, with particular emphasis on biological mechanisms associated with neurological and psychiatric disorders. Through a substantial body of peer-reviewed publications, citation impact, and interdisciplinary collaborations, his research activities demonstrate sustained engagement with scientific inquiry and knowledge dissemination.[1][2]

Abstract

This article presents an academic overview of the research accomplishments of Hamid Mostafavi Abdolmaleky. His work spans neuroscience and related biomedical disciplines, with research outputs addressing molecular, genetic, and epigenetic dimensions of brain disorders. The profile evaluates scholarly productivity, citation performance, publication record, and scientific influence within the broader research community. The information presented supports consideration for academic recognition within international award frameworks and reflects measurable indicators commonly used in research evaluation.[1][3]

Keywords

Neuroscience, Epigenetics, Psychiatric Research, Brain Disorders, Molecular Biology, Neurogenetics, Scientific Impact, Research Excellence, Biomedical Science, Academic Recognition.

Introduction

Academic recognition programs frequently assess researchers through a combination of publication quality, citation influence, research innovation, and contribution to scientific advancement. Hamid Mostafavi Abdolmaleky has established a research portfolio characterized by investigations into the biological foundations of neurological and psychiatric conditions. His scholarly activities have contributed to ongoing discussions concerning genetic regulation, molecular pathways, and translational neuroscience approaches.[2][4]

Research Profile

According to available scholarly metrics, Abdolmaleky has produced 71 indexed research documents and accumulated more than 4,072 citations from over 3,179 citing documents. His h-index of 29 indicates sustained influence across multiple publications and reflects consistent scholarly engagement over time.[1]

His institutional association with BIDMC and Harvard Medical School has supported collaborative research initiatives involving neuroscience, psychiatric genetics, molecular medicine, and translational biomedical investigations. Such collaborations contribute to the dissemination of evidence-based findings across clinical and scientific communities.[2]

Research Contributions

A major area of contribution involves the study of epigenetic mechanisms associated with psychiatric and neurological disorders. His publications have explored DNA methylation patterns, gene expression regulation, and molecular pathways that may influence disease susceptibility and progression.[4]

The research portfolio also includes investigations into biomarkers, neurodevelopmental processes, and translational approaches designed to improve scientific understanding of complex brain disorders. These studies have contributed to broader efforts aimed at integrating molecular discoveries into clinical research frameworks.[5]

Publications

The publication record includes peer-reviewed journal articles addressing neuroscience, psychiatric genetics, epigenetics, and molecular medicine. Representative works have examined DNA methylation abnormalities, epigenetic regulation in schizophrenia, and molecular factors involved in psychiatric disorders.[4][5]

The breadth of publication topics demonstrates interdisciplinary engagement and reflects the integration of laboratory-based research with clinically relevant scientific questions. The resulting body of work contributes to ongoing academic discussions within neuroscience and biomedical science communities.[3]

Research Impact

Citation indicators suggest that Abdolmaleky’s research outputs have achieved broad visibility within the scientific literature. The accumulated citation record reflects engagement by researchers from diverse disciplines and indicates continued relevance of the published findings.[1]

The influence of his work is further demonstrated through contributions to scientific understanding of gene-environment interactions, molecular pathology, and epigenetic regulation. These areas remain central to contemporary neuroscience research and continue to inform future investigations.[4][5]

Award Suitability

Consideration for the Best Researcher Award is supported by several measurable indicators, including publication productivity, citation performance, interdisciplinary collaboration, and scientific contribution within neuroscience. The combination of scholarly output, research impact, and institutional affiliation aligns with criteria commonly evaluated in international academic recognition programs.[1][2]

The profile demonstrates a sustained commitment to advancing scientific knowledge through rigorous research methodologies and peer-reviewed dissemination. These characteristics support recognition within competitive academic award environments.[3]

Conclusion

Hamid Mostafavi Abdolmaleky’s academic profile reflects a substantial contribution to neuroscience research through publication activity, citation influence, and interdisciplinary scientific engagement. His work in epigenetics and psychiatric neuroscience has contributed to the broader understanding of complex neurological conditions. Based on available scholarly indicators and research achievements, the profile demonstrates qualifications consistent with consideration for the Best Researcher Award presented through the Global Academic Awards framework.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Hamid Mostafavi Abdolmaleky, Author ID 8744606800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=8744606800
  2. Harvard Medical School. (n.d.). Faculty and research affiliation information.
    https://hms.harvard.edu/
  3. ORCID. (n.d.). ORCID record for Hamid Mostafavi Abdolmaleky.
    https://orcid.org/0000-0002-8872-5174
  4. Abdolmaleky, H. M., et al. (2007). DNA methylation and psychiatric disorders. Molecular Psychiatry.
  5. Abdolmaleky, H. M., et al. (2005). Epigenetic mechanisms in schizophrenia research. Journal of Psychiatric Research.

Lin Yuan | Neuroscience | Best Researcher Award

Lin Yuan | Neuroscience | Best Researcher Award

Prof Dr Lin Yuan, Peking University Shenzhen Hospital, China

Prof. Dr. Lin Yuan: Evaluation for Best Researcher Award.

Publication profile

Scopus

Positions and Experience

Prof. Dr. Lin Yuan is currently a Professor at the Institute of Biomedical Sciences, Peking University Shenzhen Hospital, China (since March 2021). His previous roles include serving as an Associate Professor at the Systems Biomedicine Research Institute, Peking University, from 2015 to 2017. His academic journey is bolstered by his Ph.D. and M.Sc. in Biochemistry and Molecular Biology from the Chinese People’s Liberation Army Academy of Military Medical Sciences. Additionally, he has gained valuable research experience as a Postdoctoral Fellow at UT Southwestern Medical Center (2017-2020).

Research Grants and Projects

Prof. Yuan has been actively involved in prestigious research projects funded by the National Natural Science Foundation of China (NSFC). His notable projects include studying the tumor microenvironment’s role in breast cancer progression and drug resistance, as well as exploring the regulation of p53 in lipid metabolism. His work has also focused on deubiquitinases for the tumor suppressor PTEN and its protein stability, highlighting his commitment to understanding tumorigenesis mechanisms.

Awards and Honors

Prof. Yuan’s research excellence has been recognized through various accolades. Noteworthy among these are the Outstanding Scientific Research Award from UT Southwestern Medical Center in 2020 and the First Prize of the Beijing Municipal Science and Technology Progress Award in 2017 for his research on protein homeostasis regulation. These honors underscore his contributions to advancing biomedical research.

Publications and Impact

Prof. Yuan’s research findings have been published in high-impact journals, showcasing his contributions to cancer biology, neurodegenerative diseases, and molecular biology. His work on mitochondrial regulation as a potential Alzheimer’s therapy, chemoresistance mechanisms in colorectal cancer, and neural stem cell differentiation through signaling pathways is evidence of his expertise and versatility. His publications have received citations, reflecting the academic and clinical relevance of his research.

Conclusion

Given his significant academic background, successful acquisition of competitive research grants, impactful publications, and prestigious awards, Prof. Dr. Lin Yuan is a strong candidate for the Best Researcher Award. His work not only advances scientific understanding but also contributes to developing innovative therapeutic approaches, particularly in oncology and neurobiology. Prof. Yuan’s commitment to excellence in research and his demonstrated ability to lead high-impact projects make him well-suited for recognition as a top researcher.

Publication top notes

Regulating Lars2 in mitochondria: A potential Alzheimer’s therapy by inhibiting tau phosphorylation

mTORC2-driven chromatin cGAS mediates chemoresistance through epigenetic reprogramming in colorectal cancer

Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer

HIF-1α Affects the Neural Stem Cell Differentiation of Human Induced Pluripotent Stem Cells via MFN2-Mediated Wnt/β-Catenin Signaling

PPP2R1B is modulated by ubiquitination and is essential for spermatogenesis

Downregulated hsa_circ_0036988 promotes proliferation and metastasis in oral squamous cell carcinoma